
Metacarb PG 2mg/500mg/15mg Tablet
Marketer
Argen Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metacarb PG 2mg/500mg/15mg Tablet
Combiflor PG 2mg/500mg/15mg tablets offer a combined approach to managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, resulting in reduced blood sugar. Dosage and frequency for Combiflor PG 2mg/500mg/15mg tablets should strictly follow your physician's instructions. Ingestion with food is recommended to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose. Excessive intake may cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse effects can include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor prior to initiating treatment. Pregnant or lactating individuals must consult their physician before use. Renal function assessment is typically performed before commencing therapy. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Metacarb PG 2mg/500mg/15mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Metacarb PG 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Metacarb PG 2mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metacarb PG 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Metacarb PG 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metacarb PG 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metacarb PG 2mg/500mg/15mg tablets with a meal.
How Metacarb PG 2mg/500mg/15mg Tablet works:
Metacarb PG 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple combination enhances blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metacarb PG 2mg/500mg/15mg Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Metacarb PG 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Metacarb PG 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metacarb PG 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Metacarb PG 2mg/500mg/15mg tablets cautiously, potentially requiring dose modification under medical supervision. Metacarb PG 2mg/500mg/15mg tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Metacarb PG 2mg/500mg/15mg Tablet :
Should you forget a dose of your Metacarb PG 2mg/500mg/15mg Tablet, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Metacarb PG 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Medication for diabetes |
